On the public citation graph
Methylprednisolone and Hepatotoxicity in Graves' Ophthalmopathy
0 signed · 48 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1007/bf03343835openalex-snapshot
High-dose intravenous corticosteroid therapy for Graves’ ophthalmopathy
inferredcites →https://doi.org/10.1007/bf03345386openalex-snapshot
Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves’ ophthalmopathy treated successfully with glucocorticoids themselves
inferredcites →https://doi.org/10.1007/bf03346614openalex-snapshot
Pathogenesis of Graves’ orbitopathy: A 2010 update
inferredcites →https://doi.org/10.1007/s00063-004-1014-9openalex-snapshot
[Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
inferredcites →https://doi.org/10.1016/0140-6736(91)90013-fopenalex-snapshot
Thyroid-associated eye disease: pathophysiology
inferredcites →https://doi.org/10.1016/s0021-5155(02)00544-0openalex-snapshot
Effect of High-dose Intravenous Steroid Pulse Therapy Followed by 3-Month Oral Steroid Therapy for Graves' Ophthalmopathy
inferredcites →https://doi.org/10.1034/j.1600-0420.2002.800316.xopenalex-snapshot
High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid‐associated ophthalmopathy
inferredcites →https://doi.org/10.1046/j.1365-2265.1997.2331047.xopenalex-snapshot
Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy
inferredcites →https://doi.org/10.1053/jhep.2002.34944openalex-snapshot
Diagnosis and treatment of autoimmune hepatitis
inferredcites →https://doi.org/10.1055/s-2007-1024398openalex-snapshot
Letales Leberversagen nach Corticosteroidtherapie bei Hepatitis-B-Carrier-Status
inferredcites →https://doi.org/10.1080/01676830500192167openalex-snapshot
The Philosophy of Graves' Ophthalmopathy
inferredcites →https://doi.org/10.1089/1050725041692927openalex-snapshot
Onset of Autoimmune Hepatitis During Intravenous Steroid Therapy for Thyroid-Associated Ophthalmopathy in a Patient with Hashimoto's Thyroiditis: Case Report
inferredcites →https://doi.org/10.1089/105072504774193276openalex-snapshot
Acute and Severe Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy in Patients with Graves' Ophthalmopathy
inferredcites →https://doi.org/10.1089/thy.2006.0267openalex-snapshot
Determinants of Liver Damage Associated with Intravenous Methylprednisolone Pulse Therapy in Graves' Ophthalmopathy
inferredcites →https://doi.org/10.1089/thy.2007.0315openalex-snapshot
Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy
inferredcites →https://doi.org/10.1111/j.1742-1241.2006.01004.xopenalex-snapshot
Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves’ ophthalmopathy
inferredcites →https://doi.org/10.1136/bmj.297.6663.1574openalex-snapshot
Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.
inferredcites →https://doi.org/10.1186/1740-2557-1-2openalex-snapshot
Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease
inferredcites →https://doi.org/10.1210/jc.2005-0148openalex-snapshot
Randomized, Single Blind Trial of IntravenousversusOral Steroid Monotherapy in Graves’ Orbitopathy
inferredcites →https://doi.org/10.1210/jc.86.2.501openalex-snapshot
Pathogenesis of Graves' Ophthalmopathy--Current Understanding
inferredcites →https://doi.org/10.1210/jc.86.8.3562openalex-snapshot
Comparison of the Effectiveness and Tolerability of Intravenous or Oral Glucocorticoids Associated with Orbital Radiotherapy in the Management of Severe Graves' Ophthalmopathy: Results of a Prospective, Single-Blind, Randomized Study
inferredcites →https://doi.org/10.1210/jcem-44-1-203openalex-snapshot
Modification of the Classification of the Eye Changes of Graves' Disease: Recommendations of the Ad Hoc Committee of The American Thyroid Association
inferredcites →https://doi.org/10.1507/endocrj.43.689openalex-snapshot
High-Dose Intravenous Steroid Pulse Therapy in Thyroid-Associated Ophthalmopathy.
inferredcites →https://doi.org/10.1530/acta.0.1160513openalex-snapshot
Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone pulse therapy
inferredcites →https://doi.org/10.2165/00002018-200124070-00001openalex-snapshot
Drug-Induced Liver Disorders
inferredcites →https://doi.org/10.2174/157488607780598287openalex-snapshot
Genetic and Molecular Factors in Drug-Induced Liver Injury: A Review
inferredcites →https://doi.org/10.3748/wjg.14.3374openalex-snapshot
Autoimmune liver serology: Current diagnostic and clinical challenges
inferredcites →https://doi.org/10.7326/0003-4819-104-6-826openalex-snapshot
Drug-Induced Hepatotoxicity
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4505322openalex-extracted
Graves' Disease Reduces the Risk of Hepatocellular Carcinoma: A Mendelian Randomization Study
inferred← citeshttps://doi.org/10.1007/978-3-662-46528-8_9openalex-snapshot
Thyroid Eye Disease: A Comprehensive Review
inferred← citeshttps://doi.org/10.1007/978-81-322-1807-4_23openalex-snapshot
Management of Fulminant Thyroid Eye Disease
inferred← citeshttps://doi.org/10.1007/s12020-016-0928-3openalex-snapshot
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy
inferred← citeshttps://doi.org/10.1007/s40618-014-0227-xopenalex-snapshot
Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves’ orbitopathy
inferred← citeshttps://doi.org/10.1007/s43440-023-00567-0openalex-snapshot
Safety of non-standard regimen of systemic steroid therapy in patients with Graves’ orbitopathy: a single-centre experience
inferred← citeshttps://doi.org/10.1038/eye.2012.284openalex-snapshot
Acute thyroid eye disease (TED): Principles of medical and surgical management
inferred← citeshttps://doi.org/10.1089/thy.2012.2201.edopenalex-snapshot
High-Dose Intravenous Glucocorticoid Therapy for Graves' Ophthalmopathy: Where Are We Now?
inferred← citeshttps://doi.org/10.1111/ceo.12317openalex-snapshot
Meta‐analysis of methylprednisolone pulse therapy for G raves' ophthalmopathy
inferred← citeshttps://doi.org/10.1155/2015/835979openalex-snapshot
Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves’ Orbitopathy
inferred← citeshttps://doi.org/10.1155/2018/1978590openalex-snapshot
Influence of Methylprednisolone Pulse Therapy on Liver Function in Patients with Graves’ Orbitopathy
inferred← citeshttps://doi.org/10.1177/2042018820958335openalex-snapshot
Glucocorticoids in Graves’ orbitopathy: mechanisms of action and clinical application
inferred← citeshttps://doi.org/10.1210/jc.2012-2389openalex-snapshot
Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy
inferred← citeshttps://doi.org/10.1371/journal.pone.0139544openalex-snapshot
Common Immunosuppressive Monotherapy for Graves’ Ophthalmopathy: A Meta-Analysis
inferred← citeshttps://doi.org/10.1530/eje-13-0611openalex-snapshot
The therapeutic outcome of intravenous steroid therapy for active Graves' orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor
inferred← citeshttps://doi.org/10.3389/fendo.2023.1160936openalex-snapshot
Efficacy and Safety of intravenous monoclonal antibodies in patients with moderate-to-severe active Graves’ophthalmopathy: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.35749/journal.v43i1.131openalex-snapshot
Outcome and Safety of Different Cumulative Doses and Protocols of Intravenous Methylprednisolone in Moderate to Severe and Active Graves’ Ophthalmopathy
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.